Strikingly, mice with intracranial LLC treated with VEGF-C mRNA survived longer and showed decreased tumor volume compared to those treated with control mRNA after RT (Supplementary information, Fig. S12a–d), which might be due to increased DC trafficking and CD8+ T cell activation (Supplementary information, Fig. S12e–j). The gene discussed is CD8A; the disease is neoplasm.